 
                        | Product NDC: | 36987-1817 | 
| Proprietary Name: | Mosquito | 
| Non Proprietary Name: | Mosquito | 
| Active Ingredient(s): | .05 g/mL & nbsp; Mosquito | 
| Administration Route(s): | INTRADERMAL; SUBCUTANEOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 36987-1817 | 
| Labeler Name: | Nelco Laboratories, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | BLA102192 | 
| Marketing Category: | BLA | 
| Start Marketing Date: | 19720829 | 
| Package NDC: | 36987-1817-4 | 
| Package Description: | 50 mL in 1 VIAL, MULTI-DOSE (36987-1817-4) | 
| NDC Code | 36987-1817-4 | 
| Proprietary Name | Mosquito | 
| Package Description | 50 mL in 1 VIAL, MULTI-DOSE (36987-1817-4) | 
| Product NDC | 36987-1817 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Mosquito | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRADERMAL; SUBCUTANEOUS | 
| Start Marketing Date | 19720829 | 
| Marketing Category Name | BLA | 
| Labeler Name | Nelco Laboratories, Inc. | 
| Substance Name | AEDES TAENIORHYNCHUS | 
| Strength Number | .05 | 
| Strength Unit | g/mL | 
| Pharmaceutical Classes | Non-Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient] |